KASHONDRA HARRIS: Open Payments
NPI 1104458751 · KENNESAW, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 15 payments from 8 companies in 2025. Trend: 2023 $301 · 2024 $162 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $57 |
| SHIELD THERAPEUTICS INC | 2 | $49 |
| Lilly USA, LLC | 2 | $31 |
| Corcept Therapeutics | 1 | $27 |
| Phadia US Inc. | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
Products named: Wegovy, ACCRUFER, AIRSUPRA, MOUNJARO, Korlym, ImmunoCAP, TZIELD, VRAYLAR.
Industry payments across GA — which companies pay providers there.
